USPTO serial 98105661
EIT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 2, 2025
- Examiner
- MARSH, LAURA KATHLEEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic newsletters in the fields of cancer prevention, cancer screening, cancer diagnosis, cancer treatment, digital health, health data, healthcare access, disease prevention, and medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; audio visual recordings featuring information on digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; downloadable mobile applications using artificial intelligence for use in creating, developing, sharing and analyzing data in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science | ACTIVE | Oct 30, 2023 |
| 035 | public advocacy to promote awareness and policy change in the fields of cancer prevention, cancer screening, cancer diagnosis, cancer treatment, digital health, health data, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; promoting the exchange of information and resources within the scientific and medical research community and the technology industry to achieve advances in the fields of health, digital health, health data, healthcare access, disease prevention, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; promoting public awareness and public advocacy of the need for vaccination by means of public advocacy; compilation of statistics; market research; arranging, conducting and hosting of exhibitions for business and advertising purposes; business management and consulting services, namely, managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, pricing forecasting, supply and demand forecasting and product distribution processes for others; economic forecasting services; market forecasting; commercial assistance relating to system implementation and system integration; business consulting services relating to the integration of the areas of business process technology, organizational learning, change management, and operational sustainability; collection and analysis of quality metric data in the fields of health, digital health, health data, healthcare access, disease prevention, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science for business purposes; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, providing information management services | ACTIVE | Oct 30, 2023 |
| 036 | providing educational and research scholarships and financial administration of a scholarship program; philanthropic and charitable services, namely, providing grants for education and research; providing grants to others in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; venture capital services, namely, investment funding of companies and organizations; charitable services, namely, providing financial assistance for programs and services of others; financial forecasting services | ACTIVE | Oct 30, 2023 |
| 041 | Providing classes, workshops, seminars and conferences all in the fields of cancer prevention, cancer screening, cancer diagnosis, cancer treatment, digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; educational services, namely, providing courses of instruction at the high school, undergraduate and graduate level in the fields of cancer prevention, cancer screening, cancer, diagnosis, cancer treatment, digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; providing information in the fields of education via a website; providing a website featuring blogs and non-downloadable publications in the nature of articles in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; publication of educational and training guides; production of films for educational purposes; organization of educational competitions and awards to demonstrate excellence in the fields of digital health, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; arranging, conducting, and hosting business conferences in the fields of cancer prevention, cancer screening, cancer diagnosis, cancer treatment, digital health, health data, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; arranging, conducting, and hosting business seminars in the fields of cancer prevention, cancer screening, cancer diagnosis, cancer treatment, digital health, health data, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science | ACTIVE | Oct 30, 2023 |
| 042 | Medical and scientific research in the fields of cancer treatment, cancer diagnosis, digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; development of biomedical technologies and products for others in the nature of biomedical education technologies; providing information in the fields of medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; scientific research in the fields of medicine; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of pharmaceuticals and vaccines; biotechnology research services, and research and development of new products in the fields of gene therapeutics; design of genetic research tools and systems for others; compiling data for research purposes in the fields of medical science; scientific research and development, namely, development of new scientific computational technologies to predict positive and negative regulators of gene network function; developing new technology for others in the field of computational genomics; genome sequencing services for scientific and research purposes; providing genetic sequencing and consulting services for clinical research purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; vaccine research and development; application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software, and web sites, of others in the fields of cancer treatment, cancer diagnosis, digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; research in the field of artificial intelligence; providing temporary use of nondownloadable software using artificial intelligence for use in creating, developing, sharing and analyzing data in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; genetic testing for medical research purposes; providing genetic sequencing and consulting services for medical research purposes | ACTIVE | Oct 30, 2023 |
| 044 | Providing information in the fields of cancer prevention, screening, diagnosis and treatment; providing a website featuring information in the fields of the diagnosis and treatment of cancer; healthcare services, namely, treatment and diagnosis of cancer; healthcare medical diagnostic testing, monitoring and reporting services for research purposes; consulting services in the fields of diagnostic medical testing; health care services for treating cancer | ACTIVE | Oct 30, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ELLISON INSTITUTE OF TECHNOLOGY, OXFORD LIMITED
- Other trademarks owned by ELLISON INSTITUTE OF TECHNOLOGY, OXFORD LIMITED
- Other trademarks owned by ELLISON INSTITUTE, LLC
- Other trademarks owned by ELLISON INSTITUTE, LLC
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EIT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 9, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 9, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 2, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 2, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 10, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 10, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 29, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 28, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 22, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 21, 2025 | IUAF | USE AMENDMENT FILED | — |
| May 21, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 21, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 21, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 21, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 14, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 13, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 13, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 13, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 20, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 23, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 11, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 9, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 8, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 8, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 31, 2023 | NWAP | NEW APPLICATION ENTERED | — |